STOCK TITAN
  1. Home
  2. HX

HX Stock Price, News & Analysis

HX NASDAQ

Company Description

HX (NASDAQ: HX) is a publicly traded all other nondepository credit intermediation company in the Finance and Insurance sector.

HX stock has declined 14.5% over the past year.

This page provides a comprehensive overview of HX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-14.5%
Performance 1 year
$0.0
Market Cap
48.9M
Shares outstanding

HX (HX) stock. Over the past 12 months, the stock has lost 14.5%.

Latest News

View All
—

Akso Health Group Receives Notice of Filing Delinquency From Nasdaq

—

Akso Health Group Announces Effective Date of Name Change and Ticker Symbol Change

-4.27%

Akso Health Group Reports Unaudited Financial Results for First Half of Fiscal Year 2022

earnings
+17.98%

Xiaobai Maimai Announces the Results of Annual General Meeting and Name Change

-38.51%

Xiaobai Maimai Appoints Dr. Yingxian Liu as Medical Consultant for We Health Limited

management
-0.53%

Xiaobai Maimai Plans to Enter the U.S. Radiation Oncology Services Market

HX has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, management. View all HX news →

SEC Filings

View All

No SEC filings available for HX.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

HX Company Profile & Sector Positioning

HX (HX) operates in the All Other Nondepository Credit Intermediation industry within the broader Finance and Insurance sector and is listed on the NASDAQ.